TipRanks
Mediwelcome Healthcare Management & Technology Inc. (HK:2159)
:2159
Hong Kong Market
Want to see HK:2159 full AI Analyst Report?

Mediwelcome Healthcare Management & Technology Inc. (2159) Ratios

1 Followers

Mediwelcome Healthcare Management & Technology Inc. Ratios

HK:2159's free cash flow for Q2 2026 was ¥0.30. For the 2026 fiscal year, HK:2159's free cash flow was decreased by ¥ and operating cash flow was ¥0.09. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
0.71 1.89 1.37 1.96 2.32
Quick Ratio
0.71 1.89 1.37 1.96 2.47
Cash Ratio
0.56 1.20 0.61 0.87 1.28
Solvency Ratio
0.14 0.13 -0.35 -0.78 -0.59
Operating Cash Flow Ratio
0.02 0.03 -0.12 -0.82 -0.17
Short-Term Operating Cash Flow Coverage
0.06 0.06 -0.36 -3.51 -2.03
Net Current Asset Value
¥ -90.73M¥ 71.04M¥ 40.05M¥ 86.72M¥ 134.30M
Leverage Ratios
Debt-to-Assets Ratio
0.15 0.29 0.25 0.15 0.08
Debt-to-Equity Ratio
0.50 0.49 0.67 0.27 0.14
Debt-to-Capital Ratio
0.33 0.33 0.40 0.21 0.12
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
3.45 1.71 2.73 1.85 1.63
Debt Service Coverage Ratio
0.42 0.05 -0.88 -3.25 -6.95
Interest Coverage Ratio
16.54 1.30 -33.31 -62.82 -77.88
Debt to Market Cap
0.17 0.22 0.42 0.24 0.04
Interest Debt Per Share
0.29 0.25 0.25 0.17 0.15
Net Debt to EBITDA
-2.66 -15.97 0.71 0.66 1.62
Profitability Margins
Gross Profit Margin
24.92%20.24%15.86%9.02%10.07%
EBIT Margin
4.41%0.39%-11.26%-28.70%-27.77%
EBITDA Margin
4.86%0.60%-10.45%-22.49%-21.36%
Operating Profit Margin
4.41%0.39%-11.26%-24.72%-30.01%
Pretax Profit Margin
5.04%1.49%-14.05%-29.09%-28.15%
Net Profit Margin
5.94%2.13%-14.07%-28.40%-27.58%
Continuous Operations Profit Margin
5.04%1.49%-14.60%-29.00%-28.99%
Net Income Per EBT
117.82%143.05%100.16%97.63%97.99%
EBT Per EBIT
114.30%383.84%124.75%117.66%93.82%
Return on Assets (ROA)
7.54%5.24%-23.31%-43.90%-28.07%
Return on Equity (ROE)
28.00%8.97%-63.60%-81.03%-45.74%
Return on Capital Employed (ROCE)
12.53%1.69%-47.00%-67.12%-46.26%
Return on Invested Capital (ROIC)
9.47%1.14%-29.92%-54.03%-42.61%
Return on Tangible Assets
15.56%5.51%-23.31%-43.90%-31.05%
Earnings Yield
10.39%4.17%-48.39%-106.36%-39.40%
Efficiency Ratios
Receivables Turnover
25.82 9.24 6.38 5.83 4.22
Payables Turnover
41.16 28.38 7.20 9.33 8.55
Inventory Turnover
0.00 0.00 0.00 0.00 -18.82
Fixed Asset Turnover
95.02 55.31 27.87 30.83 21.00
Asset Turnover
1.27 2.46 1.66 1.55 1.02
Working Capital Turnover Ratio
419.01 7.97 4.85 2.86 1.79
Cash Conversion Cycle
5.27 26.66 6.47 23.54 24.47
Days of Sales Outstanding
14.14 39.52 57.20 62.65 86.56
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 -19.39
Days of Payables Outstanding
8.87 12.86 50.73 39.11 42.70
Operating Cycle
14.14 39.52 57.20 62.65 67.17
Cash Flow Ratios
Operating Cash Flow Per Share
0.02 0.01 -0.07 -0.39 -0.10
Free Cash Flow Per Share
0.02 0.01 -0.14 -0.40 -0.12
CapEx Per Share
<0.01 <0.01 0.07 <0.01 0.02
Free Cash Flow to Operating Cash Flow
0.93 0.86 1.93 1.02 1.23
Dividend Paid and CapEx Coverage Ratio
13.46 7.03 -1.08 -47.18 -4.30
Capital Expenditure Coverage Ratio
13.46 7.03 -1.08 -47.18 -4.30
Operating Cash Flow Coverage Ratio
0.06 0.05 -0.29 -2.43 -0.70
Operating Cash Flow to Sales Ratio
<0.01 <0.01 -0.04 -0.23 -0.06
Free Cash Flow Yield
0.96%1.03%-28.99%-87.25%-10.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
10.30 23.99 -2.07 -0.94 -2.54
Price-to-Sales (P/S) Ratio
0.68 0.51 0.29 0.27 0.70
Price-to-Book (P/B) Ratio
2.50 2.15 1.31 0.76 1.16
Price-to-Free Cash Flow (P/FCF) Ratio
103.79 96.86 -3.45 -1.15 -9.95
Price-to-Operating Cash Flow Ratio
80.72 83.09 -6.65 -1.17 -12.27
Price-to-Earnings Growth (PEG) Ratio
0.01 -0.20 0.04 -0.45 <0.01
Price-to-Fair Value
2.50 2.15 1.31 0.76 1.16
Enterprise Value Multiple
11.35 69.34 -2.07 -0.53 -1.65
Enterprise Value
313.40M 194.78M 69.57M 39.25M 114.31M
EV to EBITDA
11.35 69.34 -2.07 -0.53 -1.65
EV to Sales
0.55 0.42 0.22 0.12 0.35
EV to Free Cash Flow
84.09 78.72 -2.57 -0.51 -5.02
EV to Operating Cash Flow
77.84 67.53 -4.95 -0.52 -6.19
Tangible Book Value Per Share
-0.22 0.42 0.38 0.63 0.92
Shareholders’ Equity Per Share
0.57 0.49 0.37 0.61 1.05
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 -0.04 <0.01 -0.03
Revenue Per Share
2.49 2.05 1.68 1.73 1.74
Net Income Per Share
0.15 0.04 -0.24 -0.49 -0.48
Tax Burden
1.18 1.43 1.00 0.98 0.98
Interest Burden
1.14 3.84 1.25 1.01 1.01
Research & Development to Revenue
0.09 0.06 0.06 0.10 0.16
SG&A to Revenue
0.12 0.14 0.19 0.15 0.15
Stock-Based Compensation to Revenue
0.00 0.00 0.00 >-0.01 0.02
Income Quality
0.12 0.30 0.31 0.78 0.20
Currency in CNY